| Schizophrenia—an overview RA McCutcheon, TR Marques, OD Howes JAMA psychiatry 77 (2), 201-210, 2020 | 1117 | 2020 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 1026 | 2017 |
| Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium TGM Van Erp, E Walton, DP Hibar, L Schmaal, W Jiang, DC Glahn, ... Biological psychiatry 84 (9), 644-654, 2018 | 790 | 2018 |
| High-potency cannabis and the risk of psychosis M Di Forti, C Morgan, P Dazzan, C Pariante, V Mondelli, TR Marques, ... The British Journal of Psychiatry 195 (6), 488-491, 2009 | 749 | 2009 |
| Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study M Di Forti, A Marconi, E Carra, S Fraietta, A Trotta, M Bonomo, F Bianconi, ... The Lancet Psychiatry 2 (3), 233-238, 2015 | 678 | 2015 |
| Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users M Di Forti, H Sallis, F Allegri, A Trotta, L Ferraro, SA Stilo, A Marconi, ... Schizophrenia bulletin 40 (6), 1509-1517, 2014 | 589 | 2014 |
| The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment AH Ashok, TR Marques, S Jauhar, MM Nour, GM Goodwin, AH Young, ... Molecular psychiatry 22 (5), 666-679, 2017 | 490 | 2017 |
| Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment V Mondelli, P Dazzan, N Hepgul, M Di Forti, M Aas, A D'Albenzio, ... Schizophrenia research 116 (2-3), 234-242, 2010 | 349 | 2010 |
| Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ... Psychological medicine 46 (15), 3231-3240, 2016 | 315 | 2016 |
| Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis V Mondelli, S Ciufolini, M Belvederi Murri, S Bonaccorso, M Di Forti, ... Schizophrenia bulletin 41 (5), 1162-1170, 2015 | 307 | 2015 |
| Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users M Di Forti, C Iyegbe, H Sallis, A Kolliakou, MA Falcone, A Paparelli, ... Biological psychiatry 72 (10), 811-816, 2012 | 306 | 2012 |
| An examination of polygenic score risk prediction in individuals with first-episode psychosis E Vassos, M Di Forti, J Coleman, C Iyegbe, D Prata, J Euesden, P O’Reilly, ... Biological psychiatry 81 (6), 470-477, 2017 | 249 | 2017 |
| Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures EF Osimo, K Beck, T Reis Marques, OD Howes Molecular psychiatry 24 (4), 549-561, 2019 | 237 | 2019 |
| Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies TR Marques, AH Ashok, T Pillinger, M Veronese, FE Turkheimer, ... Psychological medicine 49 (13), 2186-2196, 2019 | 227 | 2019 |
| Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats EC Onwordi, EF Halff, T Whitehurst, A Mansur, MC Cotel, L Wells, ... Nature communications 11 (1), 246, 2020 | 204 | 2020 |
| Cognitive change in schizophrenia and other psychoses in the decade following the first episode J Zanelli, J Mollon, S Sandin, C Morgan, P Dazzan, I Pilecka, ... American Journal of Psychiatry 176 (10), 811-819, 2019 | 198 | 2019 |
| Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis V Mondelli, CM Pariante, S Navari, M Aas, A D'Albenzio, M Di Forti, ... Schizophrenia research 119 (1-3), 75-78, 2010 | 195 | 2010 |
| White matter integrity as a predictor of response to treatment in first episode psychosis T Reis Marques, H Taylor, C Chaddock, F Dell’Acqua, R Handley, ... Brain 137 (1), 172-182, 2014 | 166 | 2014 |
| Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis M Aas, P Dazzan, V Mondelli, T Toulopoulou, A Reichenberg, M Di Forti, ... Psychological medicine 41 (3), 463-476, 2011 | 150 | 2011 |
| Cortical folding defects as markers of poor treatment response in first-episode psychosis L Palaniyappan, TR Marques, H Taylor, R Handley, V Mondelli, ... JAMA psychiatry 70 (10), 1031-1040, 2013 | 139 | 2013 |